Hints and tips:
...The deal was also likely to revive takeover speculation around Perrigo, as well as putting Merck back in the spotlight as a consolidator ahead of its Keytruda cancer treatment losing patent protection in...
...Besides Endo, recent similar inversion examples include Perrigo, Horizon Pharma, Actavis, Alkermes, Jazz Pharmaceuticals, Covidien and Forest Laboratories....
International Edition